Moroi Morgan K, Feng Iris, Vinogradsky Alice V, Yang Christine G, Nguyen Stephanie N, Kalfa David M, Goldstone Andrew B, Bacha Emile A
Division of Cardiac, Thoracic, and Vascular Surgery, Section of Pediatric and Congenital Cardiac Surgery, New York Presbyterian-Morgan Stanley Children's Hospital, Columbia University Irving Medical Center, New York, NY, USA.
World J Pediatr Congenit Heart Surg. 2025 Sep;16(5):585-594. doi: 10.1177/21501351251321528. Epub 2025 May 29.
BackgroundLate sequelae associated with chronic severe pulmonary regurgitation (PR) following transannular patch (TAP) repair of tetralogy of Fallot (TOF) have driven the use of alternative approaches. This study investigates mid-term pulmonic valve (PV) durability in TOF patients who underwent valve-sparing repair with intraoperative balloon dilation (VS-IBD).MethodsBetween 2010 and 2022, 139 TOF patients underwent VS-IBD (n = 66) or TAP (n = 73) repair at a single institution. Patients who underwent VS repair without IBD were excluded. Baseline differences were balanced by inverse probability of treatment weighting (IPTW). Primary outcome was freedom from reintervention, with median follow-up of 4.6 years.ResultsValve-sparing repair with intraoperative balloon dilation patients were older (117 vs 64 days, = .001) with higher PV annulus z-scores (-2.26 vs -2.62, = .001) compared with TAP patients. After IPTW, VS-IBD patients had a higher reintervention rate (12.6% vs 2.2%, = .028). At five years, 37/66 (56%) of VS-IBD patients remained free from ≥ moderate PR and 56/66 (85%) free from ≥ moderate pulmonic stenosis (PS). At the latest follow-up, VS-IBD patients demonstrated less right ventricular (RV) dilation (severe: 1.0% vs 15.5%, = .002) and similar RV function (normal: 88.0% vs 91.8%, = .273) as their TAP counterparts. In multivariable Cox analysis of VS-IBD patients, female sex (hazard ratio, HR [95% confidence interval, CI]: 4.4 [1.5, 13.2], = .008) and preoperative PV z-score -2.67 to -2.18 (HR [95% CI]: 5.7 [1.6, 19.6], = .006) were risk factors for developing ≥ moderate PR.ConclusionsDespite a higher early reintervention rate, the trade-off for VS-IBD patients appears to be better-preserved valve competency overall, as well as less adverse RV remodeling.
法洛四联症(TOF)经环带补片(TAP)修复术后慢性重度肺动脉反流(PR)相关的晚期后遗症促使人们采用替代方法。本研究调查了接受术中球囊扩张瓣膜保留修复术(VS-IBD)的TOF患者的中期肺动脉瓣(PV)耐久性。
2010年至2022年期间,139例TOF患者在单一机构接受了VS-IBD(n = 66)或TAP(n = 73)修复术。排除未进行IBD的VS修复患者。通过治疗权重的逆概率(IPTW)平衡基线差异。主要结局是无需再次干预,中位随访时间为4.6年。
与TAP患者相比,接受术中球囊扩张瓣膜保留修复术的患者年龄更大(117天对64天,P = .001),PV瓣环z值更高(-2.26对-2.62,P = .001)。经过IPTW后,VS-IBD患者的再次干预率更高(12.6%对2.2%,P = .028)。在五年时,66例VS-IBD患者中有37例(56%)无≥中度PR,56例(85%)无≥中度肺动脉狭窄(PS)。在最近一次随访时,VS-IBD患者的右心室(RV)扩张程度较轻(重度:1.0%对15.5%,P = .002),RV功能与TAP患者相似(正常:88.0%对91.8%,P = .273)。在对VS-IBD患者的多变量Cox分析中,女性(风险比,HR[95%置信区间,CI]:4.4[1.5,13.2],P = .008)和术前PV z值-2.67至-2.18(HR[95%CI]:5.7[1.6,19.6],P = .006)是发生≥中度PR的危险因素。
尽管早期再次干预率较高,但VS-IBD患者的权衡似乎是总体上瓣膜功能保留更好,以及RV不良重塑较少。